Progress in the management of paraneoplastic neurological disorders

Therapeutic Advances in Neurological Disorders

Volumn 3, Issue 1, 2010, Pages 43-52

  Sadeghian, Hamid ^a   Vernino, Steven ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

cyclophosphamide; intravenous immunoglobulin; limbic encephalitis; neuroimmunology; plasma exchange

Indexed keywords

3,4 DIAMINOPYRIDINE; ANTIGEN; AUTOANTIBODY; AZATHIOPRINE; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB; STEROID; TACROLIMUS;

BONE MARROW SUPPRESSION; CANCER DIAGNOSIS; CANCER THERAPY; CASE STUDY; CEREBELLUM DEGENERATION; CEREBROSPINAL FLUID; CLINICAL FEATURE; CLINICAL TRIAL; EATON LAMBERT SYNDROME; HEADACHE; HEMORRHAGIC CYSTITIS; HUMAN; IMMUNOMODULATION; LYMPHOPROLIFERATIVE DISEASE; MONOTHERAPY; MYELOPROLIFERATIVE DISORDER; MYOKYMIA; NAUSEA; ONCOLOGY; OPSOCLONUS MYOCLONUS SYNDROME; PARANEOPLASTIC NEUROPATHY; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RARE DISEASE; REVIEW; SENSORY NEUROPATHY; STIFF MAN SYNDROME; VOMITING;

EID: 77953386122     PISSN: 17562856     EISSN: None     Source Type: Journal    
DOI: 10.1177/1756285609349521     Document Type: Review

References (72)

1. Albert, M.L., Austin, L.M. and Darnell, R.B. ( 2000) Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann Neurol 47: 9-17.
2. Albert, M.L., Darnell, J.C., Bender, A., Francisco, L.M., Bhardwaj, N. and Darnell, R.B. ( 1998) Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nature Med 4: 1321-1324.
3. Armstrong, M.B., Robertson, P.L. and Castle, V.P. ( 2005) Delayed, recurrent opsoclonus-myoclonus syndrome responding to plasmapheresis. Pediatric Neurol 33: 365-367.
4. Basu, S. and Alavi, A. ( 2008) Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol Imaging Biol 10: 131-137.
5. Batchelor, T.T., Platten, M. and Hochberg, F.H. ( 1998) Immunoadsorption therapy for paraneoplastic syndromes. J Neuro-Oncol 40: 131-136.
6. Batson, O.A., Fantle, D.M. and Stewart, J.A. ( 1992) Paraneoplastic encephalomyelitis. dramatic response to chemotherapy alone. Cancer 69: 1291-1293.
7. Bell, J., Moran, C. and Blatt, J. ( 2008) Response to rituximab in a child with neuroblastoma and opsoclonus-myoclonus. Pediatric Blood Cancer 50: 370-371.
8. Benyahia, B., Liblau, R., Merle-Beral, H., Tourani, J.M., Dalmau, J. and Delattre, J.Y. ( 1999) Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies [see comment]. Ann Neurol 45: 162-167.
9. Bernal, F., Graus, F., Pifarre, A., Saiz, A., Benyahia, B. and Ribalta, T. ( 2002) Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis. Acta Neuropathol 103: 509-515.
10. Blaes, F., Strittmatter, M., Merkelbach, S., Jost, V., Klotz, M., Schimrigk, K. et al. (1999) Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders. J Neurol 246: 299-303.
11. Bruyland, M., van Belle, S., Schallier, D., Ebinger, G. and Martin, J.J. ( 1984) Good response of a paraneoplastic neuromyopathy to cyclophosphamide. Cancer Treat Rep 68: 787-789.
12. Castle, J., Sakonju, A., Dalmau, J. and Newman-Toker, D.E. ( 2006) Anti-Ma2-associated encephalitis with normal FDG-PET: a case of pseudo-Whipple's disease. Nature Clin Pract Neurol 2: 566-572.
13. Cocconi, G., Ceci, G., Juvarra, G., Minopoli, M.R., Cocchi, T., Fiaccadori, F. et al. (1985) Successful treatment of subacute cerebellar degeneration in ovarian carcinoma with plasmapheresis. A case report. Cancer 56: 2318-2320.
14. Counsell, C.E., McLeod, M. and Grant, R. ( 1994) Reversal of Subacute paraneoplastic cerebellar syndrome with intravenous immunoglobulin. Neurology 44: 1184-1185.
15. Dalmau, J., Gleichman, A.J., Hughes, E.G., Rossi, J.E., Peng, X., Lai, M. et al. (2008) Anti-N-methyl-D-aspartate receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7: 1091-1098.
16. Darnell, R.B. and Posner, J.B. ( 2003) Paraneoplastic syndromes involving the nervous system. N Engl J Med 349: 1543-1554.
17. David, Y.B., Warner, E., Levitan, M., Sutton, D.M., Malkin, M.G. and Dalmau, J.O. ( 1996) Autoimmune paraneoplastic cerebellar degeneration in ovarian carcinoma patients treated with plasmapheresis and immunoglobulin. A case report. Cancer 78: 2153-2156.
18. de Beukelaar, J.W. and Sillevis Smitt, P.A. ( 2006) Managing paraneoplastic neurological disorders. Oncologist 11: 292-305.
19. Dispenzieri, A. and Gertz, M.A. ( 2004) Treatment of POEMS syndrome. Curr Treat Opt Oncol 5: 249-257.
20. Elrington, G.M., Murray, N.M., Spiro, S.G. and Newsom-Davis, J. (1991) Neurological paraneoplastic syndromes in patients with small cell lung cancer. A prospective survey of 150 patients. J Neurol, Neurosurg Psychiatry 54: 764-767.
21. Espay, A.J. and Chen, R. ( 2006) Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome. Muscle Nerve 34: 677-690.
22. Esposito, M., Penza, P., Orefice, G., Pagano, A., Parente, E., Abbadessa, A. et al. (2008) Successful treatment of paraneoplastic cerebellar degeneration with rituximab. J Neuro-Oncol 86: 363-364.
23. Faris, M., Abraham, J. and Barrett-Lee, P. ( 1998) A patient with breast cancer and paraneoplastic cerebellar syndrome associated with anti-Purkinje cell antibodies: response to CMF chemotherapy. Clin Oncol (Royal Coll Radiol) 10: 202-203.
24. Furneaux, H.F., Reich, L. and Posner, J.B. ( 1990) Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology 40: 1085-1091.
25. Glantz, M.J., Biran, H., Myers, M.E., Gockerman, J.P. and Friedberg, M.H. ( 1994) The radiographic diagnosis and treatment of paraneoplastic central nervous system disease. Cancer 73: 168-175.
26. Graus, F., Delattre, J.Y., Antoine, J.C., Dalmau, J., Giometto, B., Grisold, W. et al. (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol, Neurosurg Psychiatry 75: 1135-1140.
27. Grisold, W., Drlicek, M., Liszka-Setinek, U. and Wondrusch, E. ( 1995) Anti-tumour therapy in paraneoplastic neurological disease. Clin Neurol Neurosurg 97: 106-111.
28. Gultekin, S.H., Rosenfeld, M.R., Voltz, R., Eichen, J., Posner, J.B. and Dalmau, J. ( 2000) Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 123: 1481-1494.
29. Guy, J. and Aptsiauri, N. ( 1999) Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. Arch Ophthalmol 117: 471-477.
30. Hayward, K., Jeremy, R.J., Jenkins, S., Barkovich, A.J., Gultekin, S.H., Kramer, J. et al. (2001) Long-term neurobehavioral outcomes in children with neuroblastoma and opsoclonus-myoclonus-ataxia syndrome: relationship to mri findings and antineuronal antibodies. J Pediatr 139: 552-559.
31. Hetzel, D.J., Stanhope, C.R., O'Neill, B.P. and Lennon, V.A. ( 1990) Gynecologic cancer in patients with subacute cerebellar degeneration predicted by anti-purkinje cell antibodies and limited in metastatic volume. Mayo Clinic Proc 65: 1558-1563.
32. Jean, W.C., Dalmau, J., Ho, A. and Posner, J.B. ( 1994) Analysis of the IgG subclass distribution and inflammatory infiltrates in patients with anti-Hu-associated paraneoplastic encephalomyelitis. Neurology 44: 140-147.
33. Keime-Guibert, F., Graus, F., Broet, P., Rene, R., Molinuevo, J.L., Ascaso, C. et al. (1999) Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor. Neurology 53: 1719-1723.
34. Keime-Guibert, F., Graus, F., Fleury, A., Rene, R., Honnorat, J., Broet, P. et al. (2000) Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol, Neurosurg Psychiatry 68: 479-482.
35. Lawn, N.D., Westmoreland, B.F., Kiely, M.J., Lennon, V.A. and Vernino, S. ( 2003) Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc 78: 1363-1368.
36. Linke, R., Schroeder, M., Helmberger, T. and Voltz, R. ( 2004) Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis. Neurology 63: 282-286.
37. Lockman, J. and Burns, T.M. ( 2007) Stiff-person syndrome. Pract Neurol 7: 106-108.
38. Maddison, P., Newsom-Davis, J., Mills, K.R. and Souhami, R.L. (1999) Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma. Lancet 353: 117-118.
39. Mathew, R.M., Vandenberghe, R., Garcia-Merino, A., Yamamoto, T., Landolfi, J.C., Rosenfeld, M.R. et al. (2007) Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis. Neurology 68: 900-905.
40. McEvoy, K.M. ( 1994) Diagnosis and treatment of Lambert-Eaton myasthenic syndrome. Neurolog Clin 12: 387-399.
41. Molina-Garrido, M., Guillèn-Ponce, C., Martinez, S. and Guirado-Risueno, M. ( 2006) Diagnosis and current treatment of neurological paraneoplastic syndromes. Clin Transl Oncol 8: 796-801.
42. Moll, J.W., Henzen-Logmans, S.C., van der Meche, F.G. and Vecht, C.H. ( 1993) Early diagnosis and intravenous immune globulin therapy in paraneoplastic cerebellar degeneration. J Neurol Neurosurg Psychiatry 56: 112.
43. Mowzoon, N. and Bradley, W.G. ( 2000) Successful immunosuppressant therapy of severe progressive cerebellar degeneration and sensory neuropathy: a case report. J Neurol Neurosurg Psychiatry 178: 63-65.
44. Newsom-Davis, J. and Mills, K.R. (1993) Immunological associations of acquired neuromyotonia (Isaacs’ syndrome) report of five cases and literature review. Brain 116: 453-469.
45. Oh, S.J., Dropcho, E.J. and Claussen, G.C. ( 1997) Anti-Hu-associated paraneoplastic sensory neuropathy responding to early aggressive immunotherapy: report of two cases and review of literature. Muscle Nerve 20: 1576-1582.
46. Oh, S.J., Slaughter, R. and Harrell, L. ( 1991) Paraneoplastic vasculitic neuropathy: a treatable neuropathy. Muscle Nerve 14: 152-156.
47. Phuphanich, S. and Brock, C. ( 2007) Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody. J Neuro-Oncol 81: 67-69.
48. Posner, J.B. and Dalmau, J.O. ( 1997) Paraneoplastic syndromes affecting the central nervous system. Ann Rev Med 48: 157-166.
49. Rauer, S. and Andreou, I. ( 2002) Tumor progression and serum anti-Hud antibody concentration in patients with paraneoplastic neurological syndromes. Eur Neurol 47: 189-195.
50. Rees, J.H., Hain, S.F., Johnson, M.R., Hughes, R.A., Costa, D.C., Ell, P.J. et al. (2001) The Role of [18f] fluoro-2-deoxyglucose-pet scanning in the diagnosis of paraneoplastic neurological disorders. Brain 124: 2223-2231.
51. Richman, D.P. and Agius, M.A. ( 2003) Treatment of autoimmune myasthenia gravis. Neurology 61: 1652-1661.
52. Rickman, O.B., Parisi, J.E., Yu, Z., Lennon, V.A. and Vernino, S. ( 2000) Fulminant autoimmune cortical encephalitis associated with thymoma treated with plasma exchange. Mayo Clin Proc 75: 1321-1326.
53. Rosenblum, M.K. ( 1993) Paraneoplasia and autoimmunologic injury of the nervous system: the anti-Hu syndrome. Brain Pathol 3: 199-212.
54. Rosenfeld, M.R. and Dalmau, J. ( 2006) Current therapies for neuromuscular manifestations of paraneoplastic syndromes. Curr Neurol Neurosci Rep 6: 77-84.
55. Rudnick, E., Khakoo, Y., Antunes, N.L., Seeger, R.C., Brodeur, G.M., Shimada, H. et al. (2001) Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the children's cancer group study [see comment]. Med Pediatr Oncol 36: 612-622.
56. Schmierer, K., Valdueza, J.M., Bender, A., Decamilli, P., David, C., Solimena, M. et al. (1998) Atypical stiff-person syndrome with spinal MRI findings, amphiphysin autoantibodies, and immunosuppression. Neurology 51: 250-252.
57. Shams'ili, S., de Beukelaar, J., Gratama, J.W., Hooijkaas, H., van den Bent, M., van ‘T Veer, M. et al. (2006) An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes. J Neurol 253: 16-20.
58. Shams'ili, S., Grefkens, J., de Leeuw, B., van den Bent, M., Hooijkaas, H., van der Holt, B. et al. (2003) Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 126: 1409-1418.
59. Sillevis Smitt, P.A., Manley, G.T. and Posner, J.B. ( 1995) Immunization with the paraneoplastic encephalomyelitis antigen HuD does not cause neurologic disease in mice. Neurology 45: 1873-1878.
60. Stark, E., Wurster, U., Patzold, U., Sailer, M. and Haas, J. ( 1995) Immunological and clinical response to immunosuppressive treatment in paraneoplastic cerebellar degeneration. Arch Neurol 52: 814-818.
61. Tanaka, M., Maruyama, Y., Sugie, M., Motizuki, H., Kamakura, K. and Tanaka, K. ( 2002) Cytotoxic T cell activity against peptides of Hu protein in anti-Hu syndrome. J Neurologic Sci 201: 9-12.
62. Tanaka, M., Tanaka, K., Tokiguchi, S., Shinozawa, K. and Tsuji, S. ( 1999) Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody. J Neurologic Sci 168: 28-31.
63. Taniguchi, Y., Tanji, C., Kawai, T., Saito, H., Marubayashi, S. and Yorioka, N. ( 2006) A case report of plasmapheresis in paraneoplastic cerebellar ataxia associated with anti-Tr antibody. Ther Apher 10: 90-93.
64. Tim, R.W., Massey, J.M. and Sanders, D.B. ( 2000) Lambert-Eaton myasthenic syndrome: electrodiagnostic findings and response to treatment. Neurology 54: 2176-2178.
65. Tüzün, E. and Dalmau, J. ( 2007) Limbic encephalitis and variants: classification, diagnosis, and treatment. Neurologist 13: 261-271.
66. Uchuya, M., Graus, F., Vega, F., Rene, R. and Delattre, J.Y. ( 1996) Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J Neurol Neurosurg Psychiatry 60: 388-392.
67. Vedeler, C.A., Antoine, J.C., Giometto, B., Graus, F., Grisold, W., Hart, I.K. et al. (2006) Management of paraneoplastic neurological syndromes: report of an EFNS task force. Eur J Neurol 13: 682-690.
68. Vernino, S. ( 2006) Paraneoplastic neurologic syndromes. Curr Neurol Neurosci Rep 6: 193-199.
69. Vernino, S., O'Neill, B.P., Marks, R.S., O'Fallon, J.R. and Kimmel, D.W. ( 2004) Immunomodulatory treatment trial for paraneoplastic neurological disorders. Neuro-Oncology 6: 55-62.
70. Weissman, D.E. and Gottschall, J.L. ( 1989) Complete remission of paraneoplastic sensorimotor neuropathy: a case associated with small-cell lung cancer responsive to chemotherapy, plasma exchange, and radiotherapy. J Clin Apher 5: 3-6.
71. Widdess-Walsh, P., Tavee, J.O., Schuele, S. and Stevens, G.H. ( 2003) Response to intravenous immunoglobulin in anti-Yo associated paraneoplastic cerebellar degeneration: case report and review of the literature. J Neuro-Oncol 63: 187-190.
72. Younes-Mhenni, S., Janier, M.F., Cinotti, L., Antoine, J.C., Tronc, F., Cottin, V. et al. (2004) FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. Brain 127: 2331-2338.